News
Beyond imaging: How blood-based biomarkers could refine prostate cancer treatment
For patients with advanced prostate cancer, treatment decisions are often made with incomplete information - leaving uncertainty about which therapies will work best.New therapies like 177Lu-PSMA-617, a targeted radioligand therapy, have…
Meeting communities where they are: Expanding access to colorectal cancer screening in Minnesota
The power of early detectionMarch is recognized as Colorectal Cancer Awareness Month, a time to highlight the importance of prevention, early detection, and equitable access to screening. Colorectal cancer remains one of the most…
Colorectal Cancer Awareness Month: Advancing research through clinical trials
Colorectal cancer is one of the most common cancers worldwide, but it is also one of the most preventable. Through screening, doctors can detect cancer early—when treatment is most effective—and in some cases prevent it entirely by…
How more than a decade of tobacco research is shaping the future of cancer prevention
Scientific progress is often described through breakthroughs, such as a new discovery, a promising treatment, or a policy shift. Yet behind nearly every meaningful advance lies something far less visible: steady, cumulative research…
The Clinical Trials Office: How clinical research is made possible
Long before a study opens to participation, months (sometimes years) of careful planning, review, and coordination is happening behind the scenes. Much of this work happens quietly, out of public view, but it is essential to the integrity…
MCC's Silvia Balbo is part of a global team to study cancer's greatest challenges
MCC program leader Silvia Balbo, also a University of Minnesota School of Public Health (SPH) professor, has been named a co-investigator on a newly-funded research team supported by Cancer Grand Challenges, a leading global…
Zooming in on a virus that can cause blood cancer
New research from the Masonic Cancer Center (MCC), University of Minnesota and the School of Dentistry is helping scientists better understand a virus linked to blood cancer. The study, recently published in Nature Communications,…
Dr. Emil Lou named to TIME’s 2026 TIME100 Health list of the world’s most influential leaders in health
The Masonic Cancer Center, University of Minnesota is pleased to announce that TIME has named Emil Lou, MD, PhD, to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health. Dr.
New artificial intelligence tool may help personalize ovarian cancer treatment from day one
Researchers from the Masonic Cancer Center, University of Minnesota in collaboration with Emory University and the Georgia Institute of Technology have developed a new artificial intelligence (AI) biomarker tool that may help predict how…
Evidence-based strategies to lower your cancer risk
Each February, National Cancer Prevention Month offers an opportunity to reflect on the choices and habits that can help reduce the likelihood of developing cancer. A growing body of research suggests that 30-50 percent of cancers are…